| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
APOH |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
2-1ug/ml, ELISA (peptide) LOD: 1:1000, Western blot: 0 |
| Notes: |
Optimal dilution of the APOH antibody should be determined by the researcher |
| Intented use: |
This APOH antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
350 |
| Purity: |
Antigen affinity |
| Description: |
Additional name(s) for this target protein: Apolipoprotein H |
| Immunogen: |
Amino acids PSIPTFATLRVYK were used as the immunogen for this APOH antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the APOH antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
APOH |
| Short name: |
APOH Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
apolipoprotein H (beta-2-glycoprotein I) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOH and IDBG-643750 and ENSBTAG00000001915 and 281006, APOH and IDBG-65172 and ENSG00000091583 and 350, Apoh and IDBG-213761 and ENSMUSG00000000049 and 11818, B2G1 and B2GP1 and BG, Extracellular, intrinsic pathway and biological process this GO :0008201 and heparin binding and molecular function this GO :0008289 and lipid binding and molecular function this GO :0009986 and cell surface and cellular component this GO :0010596 and negative regulation of endothelial cell migration and biological process this GO :0016525 and negative regulation of angiogenesis and biological process this GO :0030193 and regulation of blood coagulation and biological process this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031639 and plasminogen activation and biological process this GO :0033033 and negative regulation of myeloid cell apoptotic process and biological process this GO :0034197 and triglyceride transport and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034392 and negative regulation of smooth muscle cell apoptotic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042802 and identical protein binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0051917 and regulation of fibrinolysis and biological process this GO :0051918 and negative regulation of fibrinolysis and biological process this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0070062 and extracellular vesicular exosome and cellular component, lipoprotein lipase activator activity, this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001948 and glycoprotein binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0007597 and blood coagulation, this GO :0001948 : glycoprotein binding, this GO :0001948 : glycoprotein binding and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0008201 : heparin binding and also this GO :0008289 : lipid binding and also this GO :0042802 : identical protein binding and also this GO :0060230 : lipoprotein lipase activator activity, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0008201 : heparin binding, this GO :0008289 : lipid binding, this GO :0042802 : identical protein binding, this GO :0060230 : lipoprotein lipase activator activity, apolipoprotein H (beta-2-glycoprotein I) |
| Identity: |
616 |
| Gene: |
APOH |
More about : APOH |
| Long gene name: |
apolipoprotein H |
| Synonyms gene: |
B2G1 |
| Synonyms gene name: |
apolipoprotein H (beta-2-glycoprotein I) |
| Synonyms: |
BG |
| Synonyms name: |
beta-2-glycoprotein I |
| Locus: |
17q24, 2 |
| Discovery year: |
1987-09-11 |
| Entrez gene record: |
350 |
| Pubmed identfication: |
1582254 |
| RefSeq identity: |
NM_000042 |
| Classification: |
Sushi domain containing Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000179530 |